Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Few patients with neurodegenerative disorders require spinal surgery.
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Isolated cognitive relapses in multiple sclerosis.
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Recent achievements in stem cell-mediated myelin repair.
The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Pregnancy and multiple sclerosis.
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.
Fluctuations in appraisal over time in the context of stable versus non-stable health.
A Case Report of Obsessive-Compulsive Disorder Following Acute Disseminated Encephalomyelitis.
The Regulation of Reactive Changes Around Multiple Sclerosis Lesions by Phosphorylated Signal Transducer and Activator of Transcription.
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
Pages
« first
‹ previous
…
345
346
347
348
349
350
351
352
353
…
next ›
last »